BILL · 2011–12 SESSION
HB 1397: Medicaid agency/generics
Requiring the state medicaid agency to establish a competitive bid process for generic drug manufacturers.
Summary
- Establishes the medicaid generic drug competition and savings act. Directs the department of social and health services, as the state medicaid agency, to require certain generic drug manufacturers to compete in a competitive bid process to ensure that the agency is providing medicaid recipients with quality generic products at a competitively bid low cost.
From the Bill Digest (HB 1397), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 20, 2011
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Tami Green (D-28)
- Introduced
- January 20, 2011 in the House
- Last action
- April 11, 2012
AN ACT Relating to requiring the state medicaid agency to establish a competitive bid process for generic drug manufacturers;
Sponsors
Prime sponsor: Tami Green (D-28)
10 co-sponsors (6 Democrats, 4 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care & Wellness.
HB 1397 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 1397 (2025–26) Local property tax levies
- HB 1397 (2023–24) Dependency
- HB 1397 (2021–22) Day care/child support
- HB 1397 (2019–20) Electric aircraft
- HB 1397 (2017–18) CTC property tax exemption
- HB 1397 (2015–16) Financial reporting
- HB 1397 (2013–14) Sexual health education
- HB 1397 (2009–10) Nurse authority delegation